PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportshepatitis b
MeSH D006509 - hepatitis b
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D006525:Viral hepatitis human
0 Companies
0 Drugs
Success rate
D000086982:Blood-borne infections
0 Companies
0 Drugs
Success rate
D018347:Hepadnaviridae infections
0 Companies
0 Drugs
Success rate
D006509: 
Hepatitis b
41 Companies
17 Drugs
$
Success rate
D019694:Chronic hepatitis b
34 Companies
17 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaLamivudine, Abacavir Abacavir Lamivudine  2016-09-29   
Entecavir Entecavir  2014-08-26   
Lamivudine Lamivudine Teva  2009-10-23   
Lamivudine Lamivudine Teva Pharma B.V  2009-12-10   
Lamivudine, Zidovudine Lamivudine/Zidovudine Teva  2011-02-28   
MylanTenofovir disoproxil, Lamivudine Cimduo  2018-02-28   
Entecavir Entecavir Mylan  2017-09-18   
Lamivudine Lamivudine  2019-03-05   
Lamivudine, Zidovudine Lamivudine Zidovudine  2019-08-12   
Tenofovir disoproxil, Efavirenz, Lamivudine Symfi  2018-03-22   
Tenofovir disoproxil, Efavirenz, Lamivudine Symfi Lo  2018-02-05   
Lamivudine, Abacavir Abacavir Lamivudine  2023-12-22   
NATCO PharmaLamivudine Lamivudine  2016-03-04   
Lamivudine, Zidovudine Lamivudine Zidovudine  2014-08-28   
GSKLamivudine Epivir-hbv  1998-12-08   
Lamivudine Zeffix  1999-07-29   
CiplaLamivudine, Abacavir Abacavir Lamivudine  2017-03-28   
Entecavir Entecavir  2016-12-06   
Lamivudine Lamivudine  2017-03-03   
Lamivudine, Zidovudine Lamivudine Zidovudine  2018-09-07   
Chartwell PharmaceuticalsLamivudine, Abacavir Abacavir Lamivudine  2017-03-28   
Lamivudine, Zidovudine Lamivudine Zidovudine  2011-05-25   
Entecavir Entecavir  2017-05-11   
Tenofovir disoproxil, Lamivudine Temixys  2018-11-16   
Lamivudine Lamivudine  2014-10-31   
Lupin ResearchLamivudine, Abacavir, Zidovudine Abacavir Sulfate, Lamivudine Zidovudine  2013-12-05   
Lamivudine Lamivudine  2014-12-18   
Lamivudine, Zidovudine Lamivudine Zidovudine  2012-05-15   
NovartisTelbivudine Sebivo  2007-04-24   
Telbivudine Tyzeka 2023-09-11 2006-10-25   
Merck & CoDoravirine, Tenofovir disoproxil, Lamivudine Delstrigo 2032-08-30 2018-08-30 $249 M Y2024 
Raltegravir, Lamivudine Dutrebis 2022-10-21 2015-02-06   
Hepatitis b virus hbsag surface protein antigen HBVaxPro  2001-04-27   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
44%
11/25
Phase 2
72%
23/32
Phase 3
53%
20/38
Approved: 7Overall Success rate: 17%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Tenofovir disoproxil,
Efavirenz,
Lamivudine,
Abacavir,
Abacavir sulfate,
Zidovudine,
Tenofovir,
Fendrix
GSK
Lamivudine,
Benzocaine,
Alanine,
Edrecolomab,
Tenofovir,
Adefovir,
Carmellose,
Bepirovirsen,
Carboxymethylcellulose,
Sodium chloride,
Albinterferon alfa-2b,
Bevifimod,
Nadide,
Microcrystalline cellulose,
Edetic acid,
As03,
Synflorix,
Twinrix,
Fendrix,
Fluzone,
Prevenar13,
Prevnar13,
Menactra,
Pneumovax,
Gsk3965193,
Antacid,
Flumist,
Hepsera,
Flucelvax,
Prevenar,
Gsk3389404
Cipla
Lamivudine
Novartis
Telbivudine,
Tenofovir,
Doconexent,
Adefovir,
Albinterferon alfa-2b,
Aspartame,
Valine,
VALTORCITABINE,
Fendrix,
Arm1,
Hepsera,
Arm2
Sanofi
Lecithin,
Adefovir,
Bevifimod,
Recombivax,
Fendrix,
Prevenar13,
Prevnar13,
Pcv13,
Pneumovax,
Triapine,
Hepsera,
Prevenar
Merck & Co
Doravirine,
Raltegravir,
Tenofovir disoproxil,
Lamivudine,
Hepatitis b virus hbsag surface protein antigen,
Docusate,
Alanine,
Vicriviroc,
Tenofovir,
Alfacalcidol,
Adefovir,
Albinterferon alfa-2b,
Aspartame,
Bevifimod,
Corticorelin,
Recombivax,
Fendrix,
Fluzone,
Pneumovax,
Flumist,
Hepsera,
Flucelvax,
Prevenar,
Taxane
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use